TDC
TNDM icon

Thompson Davis & Co’s Tandem Diabetes Care TNDM Stock Holding History

Thompson Davis & Co’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-125
Closed -$3K – 788
2018
Q2 		$3K Sell
125
-3,875
-97% -$47.7K 0.01% 587
2018
Q1 		$20K Buy
+4,000
New +$12.9K 0.05% 297
2014
Q3 		– Sell
-25
Closed -$4K – 1229
2014
Q2 		$4K Hold
25
– – 0.01% 649
2014
Q1 		$6K Hold
25
– – 0.01% 606
2013
Q4 		$6K Buy
+25
New +$5.72K 0.01% 544

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Thompson Davis & Co's TNDM Position: Q3 2018 in Review

Thompson Davis & Co sold out of Tandem Diabetes Care (TNDM) in Q3 2018, closing a stake of 125 shares — an estimated $3K sold.

Thompson Davis & Co first reported a position in TNDM in Q4 2013 and held it in 5 quarters. The position peaked at $20K in Q1 2018. 184 funds tracked by Wall St. Rank hold TNDM as of Q3 2018.

  • Thompson Davis & Co reported no remaining Tandem Diabetes Care position as of Q3 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 125 Tandem Diabetes Care shares in Q3 2018, an estimated $3K.
  • Thompson Davis & Co first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 5 quarters.
  • Thompson Davis & Co's Tandem Diabetes Care position peaked at $20K in Q1 2018.
  • 184 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.